Author Archives: Mathew Lombard

AstraZeneca Asserts Its Purple Rights

Posted on November 6, 2015 by Mathew Lombard

**Update here** Global pharma giant AstraZeneca has asserted its rights to its purple trademark. AstraZeneca filed a complaint at the US District Court for the District of Delaware on 28 October, claiming Indian drug maker Dr. Reddy’s Laboratories’s generic version of Nexium … Continue reading →

Posted in Uncategorized | Tagged Business of Trademarks, Likelihood of confusion, Pharma, Trademark Litigation | 1 Comment

Ipsen & Telesta Reach Deal

Posted on October 29, 2015 by Mathew Lombard

Ipsen and Telesta Therapeutics Inc. announced yesterday that they have entered into an exclusive licensing agreement for Ipsen to develop and commercialize MCNA1 for the treatment of high risk non-muscle invasive bladder cancer (NMIBC) in all countries of the world, … Continue reading →

Posted in Pharmaceutical Trademarks, Pharmaceuticals | Leave a comment

Walmart Avoids Federal Action

Posted on October 24, 2015 by Mathew Lombard

Walmart has successfully avoided action by the Federal Trade Commission (“FTC”) concerning Walmart’s mislabeling of products as “Made in the U.S.A.,” when they were, in fact, not made in the U.S.A. The retailer was forced to remove “Made in the … Continue reading →

Posted in Uncategorized | Tagged Business, Business of Trademarks, FTC, Government Action | Leave a comment

Ninth Circuit Does About-Face

Posted on October 23, 2015 by Mathew Lombard

In its second appellate review of the same case, the Ninth Circuit has done an about-face. In its second review of the case the US Court of Appeals for the Ninth Circuit set aside its own ruling that found Amazon … Continue reading →

Posted in Uncategorized | Leave a comment

Google Books is Fair Use, According to 2nd Circuit

Posted on October 22, 2015 by Mathew Lombard

On October 16, 2015, the Second Circuit Court of Appeals confirmed that Google can digitally scan millions of books and make snippets of them available for searching. The Google Books service is a fair use under U.S. copyright law. “Google’s making … Continue reading →

Posted in Uncategorized | Tagged Copyright, Court Decisions | Leave a comment

Antibiotic Pipeline Growing…

Posted on October 21, 2015 by Mathew Lombard

“After years of growing alarm, researchers are beginning to pick up the pace of developing new drugs to treat bacterial infections, according to a new viewpoint in ACS Infectious Diseases. Five new antibiotics that can treat drug-resistant infections were approved by … Continue reading →

Posted in Uncategorized | Leave a comment

Yelp Sues South Park Creators

Posted on October 21, 2015 by Mathew Lombard

Yelp, Inc. has sued “South Park” creators, Trey Parker and Matt Stone, and Comedy Central for damages caused by the latest episode of South Park which lampooned the customer review and local business rating website, entitled “You’re Not Yelping”. Yelp seeks … Continue reading →

Posted in Uncategorized | Leave a comment

Teva to Acquire Allergan’s Generic Business

Posted on July 31, 2015 by Mathew Lombard

Teva Pharmaceuticals is buying Allergan’s generic drug business for $40.5 billion. The Israeli pharmaceutical signed an agreement on 27 July for Allergan Generics and withdrew its plans to acquire Mylan’s business. Under the new agreement, Teva will pay Allergan $33.75 … Continue reading →

Posted in Pharmaceuticals | Leave a comment

Allergan to Acquire Oculeve

Posted on July 7, 2015 by Mathew Lombard

Dublin, Ireland-based Allergan announced it will acquire San Francisco-based Oculeve for a $125 million upfront payment plus milestone payments related to Oculeve’s lead development program OD-01, a device to treat dry eye disease. The agreement also includes the acquisition of … Continue reading →

Posted in Uncategorized | Leave a comment